Catecholamines stimulate interleukin-6 synthesis in rat cardiac fibroblasts

A Bürger1, M Benicke, A Deten

  • 1Carl-Ludwig-Institut für Physiologie, Universität Leipzig, D-04103 Leipzig, Germany.

Insights

Norepinephrine significantly increases interleukin-6 (IL-6) production in rat cardiac fibroblasts, suggesting IL-6 may contribute to cardiac hypertrophy and heart disease. Carvedilol blocks this effect.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Cellular Physiology

Background:

  • Proinflammatory cytokines are key in heart disease pathophysiology.
  • Interleukin-6 (IL-6) is implicated in cardiac hypertrophy mechanisms.
  • Catecholamines are known inducers of cardiac hypertrophy.

Purpose of the Study:

  • Investigate cardiac fibroblasts as a source of IL-6 in rat hearts.
  • Determine if catecholamines modulate IL-6 synthesis in cardiac fibroblasts.

Main Methods:

  • Quantified IL-6 mRNA in rat cardiac fibroblasts.
  • Stimulated fibroblasts with norepinephrine (NE), phenylephrine, and isoproterenol.
  • Assessed the effect of carvedilol, an adrenergic antagonist.

Main Results:

  • Basal IL-6 mRNA levels in unstimulated fibroblasts were low.
  • Norepinephrine (NE) induced a 50-fold increase in IL-6 mRNA.
  • Alpha- and beta-adrenergic agonists increased IL-6; beta-receptor stimulation was more potent.
  • Carvedilol inhibited NE-induced IL-6 mRNA synthesis.

Conclusions:

  • Norepinephrine stimulates IL-6 expression in rat cardiac fibroblasts.
  • IL-6 may play an autocrine/paracrine role in cardiac hypertrophy.
  • Adrenergic signaling pathways influence IL-6 production in the heart.

Related Concept Videos